MedTrace Logo

Cumulative Irritation Test of PAC-14028 in Healthy Volunteers

NCT01638117 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2014-01-22

No results posted yet for this study

Summary

The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.

Conditions

  • Healthy

Interventions

OTHER

PAC14028-Vehicle

PAC-14028 Cream Vehicle, Daily for up to 21 days

DRUG

PAC14028-0.1

PAC-14028 Cream, 0.1%, Daily for up to 21 days

DRUG

PAC14028-0.3

PAC-14028 Cream, 0.3%, Daily for up to 21 days

DRUG

PAC14028-1.0

PAC-14028 Cream, 1%, Daily for up to 21 days

OTHER

Saline

Saline, Daily for up to 21 days

OTHER

Positive

Sodium Lauryl Sulfate, 0.5%, Daily for up to 21 days

Sponsors & Collaborators

  • Amorepacific Corporation

    lead INDUSTRY

Principal Investigators

  • Kyu-Han Kim, M.D.,Ph.D. · Seoul National University Hospital, Department of Dermatology

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01638117 on ClinicalTrials.gov